Elsevier

Clinical Imaging

Volume 35, Issue 4, July–August 2011, Pages 320-323
Clinical Imaging

A massive renal epithelioid angiomyolipoma with multiple metastatic lymph nodes

https://doi.org/10.1016/j.clinimag.2010.08.017Get rights and content

Abstract

A 47-year-old man presented with dull pain in the left upper abdomen for 1 year. Computed tomograph (CT) examination revealed a very large heterogeneously enhancing mass in the left kidney, measuring up to 28 cm. The mass was accompanied by several enlarged lymph nodes in the peri-aortic region. Radical nephrectomy was performed and pathologic evaluation revealed sheets of epithelioid cells and piecemeal necrosis consistent with malignant epithelioid angiomyolipoma (EAML) with regional lymph node metastases. The tumor cells were strongly positive for human melanosome-associated protein (HMB-45) on immunohistochemical staining. There was neither metastasis nor recurrence 2 years postoperatively. EAML is a rare tumor of mesenchymal tissue with potential for aggressive behavior. If this neoplasm is suspected based on CT features, EAML should be confirmed by pathology and immunohistochemistry.

Introduction

Epithelioid angiomyolipoma (EAML) is an unusual type of mesenchymal neoplasms which mainly occurs in the kidney. EAMLs often resemble sarcomatoid renal cell carcinoma (RCC), high-grade RCC, or sarcomas. So far, only a small number of cases of EAML have been recorded. Herein we report the case of a 47-year-old woman with a massive left renal tumor that radiographically was suggestive for renal sarcoma or RCC due to the absence of fat content with multiple enlarged lymph nodes. After nephrectomy, pathology confirmed the diagnosis of EAML.

Section snippets

Case report

A 47-year-old man was admitted to our hospital in August 2007 because of upper-left abdominal pain and discomfort for about 1 year. Physical examinations revealed normal findings except for a large, soft tumor with mild pain on percussion at the left costal margin. Results of routine laboratory tests, including complete blood count, serum glucose, and electrolytes, and tests of liver and kidney function were normal. Computed tomography (CT) imaging showed a large (28×21×12 cm) soft

Discussion

EAML was first reported by Mai et al. [1] in 1996. It is a rare mesenchymal tumor which has been gradually recognized and accepted as a distinct entity in recent years. So far, few cases (fewer than 40 cases) of clinically aggressive or malignant AML, which is histologically categorized as EAML, have been reported all over the world [2], [3]. EAML has for a long time been mistaken for a hamartoma and misclassified as angiomyolipoma (AML). In 2004, the International Agency for Research on Cancer

References (8)

There are more references available in the full text version of this article.

Cited by (0)

View full text